Back to Journals » Breast Cancer: Targets and Therapy » Volume 9

Review

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

       
Total article views   HTML views PDF downloads Totals
9,394 Dovepress* 8,187+ 1,291 9,478
PubMed Central* 1,207 616 1,823
Totals 9,394 1,907 11,301
*Since 6 December 2017

View citations on PubMed Central and Google Scholar